Ligand Pharmaceuticals Competitors
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
---|---|---|---|---|---|---|---|---|
REGN | Regeneron Pharmaceuticals | Outperform |
2
|
$903.48 | $961.26 | 16.22% | 8 | $97.47B |
EBS | Emergent BioSolutions | Outperform |
16
|
$1.93 | $5.00 | 159.07% | 0 | $101.11M |